James Mitchell, MD
Interventional Cardiology · North Kansas City, MONPI 1689890428
Payments from drug & device makers
Across 38 payments — averaging $29.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$446
- Boston Scientific$251
- Recor Medical Inc$177
- Edwards Lifesciences$123
- Medtronic$93
- Shockwave Medical, Inc$16
What the payments were for
- Food & beverage$1,106100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 20 | $446 |
| Boston Scientific | 6 | $251 |
| Recor Medical Inc | 4 | $177 |
| Edwards Lifesciences | 6 | $123 |
| Medtronic | 1 | $93 |
| Shockwave Medical, Inc | 1 | $16 |
How this compares
$1,106 in reported general payments places this provider in the 5th percentile of 182 interventional cardiology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 420 | $461,287 |
| EntrestoSacubitril/Valsartan | 39 | $45,988 |
| XareltoRivaroxaban | 38 | $36,728 |
| JardianceEmpagliflozin | 41 | $36,615 |
| Repatha SureclickEvolocumab | 23 | $28,430 |
| MultaqDronedarone Hcl | 19 | $21,845 |
| VascepaIcosapent Ethyl | 12 | $9,602 |
| Diltiazem 12hr ErDiltiazem Hcl | 21 | $5,314 |
| Potassium Chloride | 212 | $5,231 |
| Atorvastatin Calcium | 522 | $5,035 |
| Metoprolol Succinate | 392 | $4,993 |
| Carvedilol | 419 | $4,356 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 287 | $3,358 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 83 | $2,925 |
| Rosuvastatin Calcium | 256 | $2,898 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in North Kansas City
- Zafir HawaNorth Kansas City$640K
- David HahnNorth Kansas City$187K
- Harvey SerotaSaint Louis$7.1M
- Adnan ChhatriwallaKansas City$3.6M
- Gil VardiSaint Louis$2M
- Alan ZajariasSaint Louis$1.6M
- James GranthamKansas City$1.6M
- Anish ThomasSaint Louis$1.5M
- Richard BachSaint Louis$1.5M
- Joshua StolkerWashington$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.